Premature Coronary Heart Disease
6
3
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (6)
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial
the Real-world Data of Risk Factor and Its Prognosis in PREmature Coronary ARtery DIseAse Study
Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment
Correlation Between the Severity of Coronary Artery Disease and Peripheral Arterial Stiffness in Patients With Premature Coronary Heart Disease